These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 871518)

  • 1. Interrelation between plasma magnesium and 25 hydroxy-vitamin D3 levels in chronic renal failure.
    Shany S; Kushelevsky A; Berlyne GM
    Biomedicine; 1977 Apr; 26(2):108-11. PubMed ID: 871518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and erythrocyte magnesium levels in patients with chronic renal failure.
    Głuszek J
    Pol Med Sci Hist Bull (1973); 1976; 15-16(4):353-8. PubMed ID: 1005219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma 1,25 hydroxycholecalciferol concentrations and net intestinal calcium, phosphate and magnesium absorption in man.
    Ruggiero M; Brunese M; Morelli S; Salvia PF; Mangoni C; Stefano S
    Boll Soc Ital Biol Sper; 1981 Apr; 57(7):791-7. PubMed ID: 6895034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper, zinc, calcium and magnesium in chronic renal failure.
    Avasthi G; Singh HP; Katyal JC; Avasthi R; Aggarwal SP
    J Assoc Physicians India; 1991 Jul; 39(7):531-4. PubMed ID: 1800497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium-phosphate metabolism in chronic polyarthritis].
    Siegmeth W; Dudczak R; Zazgornik J
    Z Rheumatol; 1982; 41(1):16-8. PubMed ID: 7080689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hypermagnesemia on circulating plasma parathyroid hormone in patients on regular hemodialysis therapy.
    McGonigle RJ; Weston MJ; Keenan J; Jackson DB; Parsons V
    Magnesium; 1984; 3(1):1-7. PubMed ID: 6482508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxycholecalciferol in Greek uremics.
    Drivas G; Bamias J; Tsomis A; Kalos A; Douratsos D; Melissinos K
    Invest Urol; 1980 Jul; 18(1):52-3. PubMed ID: 7410014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphate excretion in chronic renal failure: evidence for a mechanism other than circulating parathyroid hormone.
    Fotino S
    Clin Nephrol; 1977 Dec; 8(6):499-503. PubMed ID: 598054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of renal transplantation on the metabolism of vitamin D3.
    Saha H; Salmela K; Ahonen J; Pietilä K; Mörsky P; Pasternack A
    Transplant Proc; 1992 Feb; 24(1):367-8. PubMed ID: 1539320
    [No Abstract]   [Full Text] [Related]  

  • 12. Parathyroid hormone plasma level in untreated chronic renal failure and in hemodialyzed patients.
    Fuss M; De Backer M; Brauman J; Nijs-Dewolf N; Manderlier T; Brauman H; Corvilain J
    Nephron; 1976; 17(2):144-54. PubMed ID: 940620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal excretion of magnesium in chronic renal failure.
    Głuszek J
    Pol Med Sci Hist Bull (1973); 1976; 15-16(4):359-62. PubMed ID: 1005220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
    Baradaran A; Nasri H
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hypomagnesemia caused by cisplatin: effect of calcitriol.
    Sutton RA; Walker VR; Halabe A; Swenerton K; Coppin CM
    J Lab Clin Med; 1991 Jan; 117(1):40-3. PubMed ID: 1987306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of 1 alpha-hydroxy vitamin D3 (0.25 micrograms/day) and calcium carbonate on patients with chronic renal failure at the predialytic stage.
    Okada K; Nagura Y; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):657-60. PubMed ID: 2795995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.